Turkey of the week: an overpriced platinum stock

Current market conditions couldn't be more favourable for this platinum-focused chemicals firm. But it looks vulnerable at its current glittering levels.

Johnson Matthey is a speciality chemicals firm focusing on platinum. The business is organised into three units: environmental technologies, precious metals and pharmaceutical materials, all of which revolve around the white metal. Its main activities include the manufacture of catalytic converters for pollution control, platinum trading and research into platinum-based cancer drugs.

Turkey of the week: Johnson Matthey (JMAT), rated as OUTPERFORM by Bear Stearns

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

Paul gained a degree in electrical engineering and went on to qualify as a chartered management accountant. He has extensive corporate finance and investment experience and is a member of the Securities Institute.

Over the past 16 years Paul has held top-level financial management and M&A roles for blue-chip companies such as O2, GKN and Unilever. He is now director of his own capital investment and consultancy firm, PMH Capital Limited.

Paul is an expert at analysing companies in new, fast-growing markets, and is an extremely shrewd stock-picker.